Healthcare -
Biotechnology - NASDAQ - US
$ 9.865
-2.23 %
$ 1.02 B
Market Cap
-1.88
P/E
NTLA - RESEARCH & DEVELOPMENT
Research & Development NTLA - Intellia Therapeutics, Inc.
435 M
LAST VALUE
37.59%
2 YEAR CAGR
37.32%
5 YEAR CAGR
0.00%
10 YEAR CAGR